TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
RPH Pharmaceuticals AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
221,246
|
154,229
|
130,743 |
| Financial expenses |
21,546
|
11,963
|
15,470 |
| Earnings before taxes |
29,839
|
24,856
|
36,439 |
| EBITDA |
73,416
|
49,798
|
39,046 |
| Total assets |
215,022
|
200,924
|
281,848 |
| Current assets |
72,734
|
63,297
|
159,502 |
| Current liabilities |
187,221
|
170,591
|
240,446 |
| Equity capital |
25,838
|
28,381
|
37,228 |
| - share capital |
67
|
67
|
73 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
12.0%
|
14.1%
|
13.2% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
13.5%
|
16.1%
|
27.9% |
| Return on assets (ROA) |
23.9%
|
18.3%
|
18.4% |
| Current ratio |
38.8%
|
37.1%
|
66.3% |
| Return on equity (ROE) |
115.5%
|
87.6%
|
97.9% |
| Change turnover |
66,223
|
34,076
|
28,589 |
| Change turnover % |
43%
|
28%
|
28% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.